---

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆

• Strides Pharma Science Limited's subsidiary has received USFDA approval for its seizures drug, Levetiracetam Oral Solution.

• The product has a market size of ~US$55 Mn and will be manufactured at the company's facility in Bengaluru.

• Strides Pharma has a target to launch ~60 new products in the US over the next three years.

https://www.moneycontrol.com/news/business/markets/stride...

#STAR